Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Helen M Sheldrake

7PUBLICATIONS

9CO-AUTHORS

Molecular targetsGlycoconjugatesCheminformatics and quantitative structure-activity relationshipsGene and molecular therapyCharacterisation of biological macromolecules

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 23, 2025

K562 Chronic Myeloid Leukemia Cells as a Dual β3-Expressing Functional Cell Line Model to Investigate the Effects of Combined αIIbβ3 and αvβ3 Antagonism.

Amal A Elsharif, Laurence H Patterson, Steven D Shnyder

|Apr 29, 2025

Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid.

Dania Alhyari, Nidal A Qinna, Helen M Sheldrake

|Sep 16, 2024

Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.

Adam Throup, Manar Saleh Zraikat, Andrew Gordon

|Jul 27, 2024

Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy.

Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland

|Aug 26, 2023

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy.

Mark Sutherland, Andrew Gordon, Fatemah O F O Al-Shammari

|Nov 02, 2019

Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.

Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim

Pageof 2

Frequent Collaborators

2 joint publications

Mark Sutherland

2 joint publications

Steven D Shnyder

1 joint publications

Davide Bonanni

1 joint publications

Donatella Boschi

1 joint publications

Marco L Lolli

1 joint publications

Klaus Pors

1 joint publications

Fatemah O F O Al-Shammari

1 joint publications

Nidal A Qinna

1 joint publications

Sriharsha Kantamneni

Frequent Collaborators

2 joint publications

Mark Sutherland

2 joint publications

Steven D Shnyder

1 joint publications

Davide Bonanni

1 joint publications

Donatella Boschi

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on : Feb 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on : Feb 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos